Detection of Staphylococcus aureus in cystic fibrosis patients using breath VOC profiles

被引:47
|
作者
Neerincx, A. H. [1 ,3 ]
Geurts, B. P. [2 ]
van Loon, J. [3 ]
Tiemes, V. [3 ]
Jansen, J. J. [2 ]
Harren, F. J. M. [1 ]
Kluijtmans, L. A. J. [4 ]
Merkus, P. J. F. M. [3 ,5 ]
Cristescu, S. M. [1 ]
Buydens, L. M. C. [2 ]
Wevers, R. A. [4 ]
机构
[1] Radboud Univ Nijmegen, Inst Mol & Mat, Dept Mol & Laser Phys, Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Inst Mol & Mat, Dept Analyt Chem, Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Amalia Childrens Hosp, Dept Paediat, Nijmegen, Netherlands
[4] Radboud Univ Nijmegen, Med Ctr, Translat Metab Lab, Dept Lab Med, Nijmegen, Netherlands
[5] Canisius Wilhelmina Hosp, Dept Paediat, Nijmegen, Netherlands
关键词
Staphylococcus aureus; breath analysis; volatile organic compound (VOC) profiles; GC-MS; sparse partial least squares discriminant analysis (s-PLS-DA); cystic fibrosis; VOLATILE ORGANIC-COMPOUNDS; OROPHARYNGEAL CULTURES; MASS-SPECTROMETRY; GC-MS; STREPTOCOCCUS-PNEUMONIAE; PSEUDOMONAS-AERUGINOSA; VARIABLE SELECTION; SPUTUM INDUCTION; YOUNG-CHILDREN; SIFT-MS;
D O I
10.1088/1752-7155/10/4/046014
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Staphylococcus aureus (S. aureus) is a common bacterium infecting children with cystic fibrosis (CF). Since current detection methods are difficult to perform in children, there is need for an alternative. This proof of concept study investigates whether breath profiles can discriminate between S. aureus infected and non-infected CF patients based on volatile organic compounds (VOCs). We collected exhaled breath of CF patients with and without S. aureus airways infections in which VOCs were identified using gas chromatography-mass spectrometry. We classified these VOC profiles with sparse partial least squares discriminant analysis. Multivariate breath VOC profiles discriminated infected from non-infected CF patients with high sensitivity (100%) and specificity (80%). We identified the nine compounds most important for this discrimination. We successfully detected S. aureus infection in CF patients, using breath VOC profiles. Nine highlighted compounds can be used as a focus point in further biomarker identification research. The results show considerable potential for non-invasive diagnosis of airway infections.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Exhaled breath profiles to detect lung infection with Staphylococcus aureus in children with cystic fibrosis
    Licht, Johann-Christoph
    Seidl, Elias
    Slingers, Gitte
    Waters, Valerie
    de Vries, Rianne
    Post, Martin
    Ratjen, Felix
    Grasemann, Hartmut
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2023, 22 (05) : 888 - 893
  • [2] Staphylococcus aureus and cystic fibrosis
    Mimica, Marcelo J.
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2012, 11 (01) : 71 - 71
  • [3] STAPHYLOCOCCUS AUREUS IN CYSTIC FIBROSIS
    Moonnumakal, S. P.
    Hulten, K. G.
    Mason, E. O.
    Kaplan, S. L.
    Hiatt, P. W.
    [J]. PEDIATRIC PULMONOLOGY, 2010, : 336 - 336
  • [4] Linezolid Resistant Staphylococcus Aureus in Patients With Cystic Fibrosis
    Fischer, A. J.
    Pitcher, N.
    Feder, A.
    Bolden, N.
    Zirbes, C.
    Thurman, A.
    Reeb, V.
    Moustafa, A.
    Porterfield, H.
    Planet, P. J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [5] Antimicrobial Treatment of Staphylococcus aureus in Patients With Cystic Fibrosis
    Esposito, Susanna
    Pennoni, Guido
    Mencarini, Valeria
    Palladino, Nicola
    Peccini, Laura
    Principi, Nicola
    [J]. FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [6] Improved culture detection of Staphylococcus aureus from sputum of patients with cystic fibrosis (CF)
    Wen, Hongjie
    Stirling, Jonathan
    McCaughan, John
    Schock, Bettina
    Downey, Damian G.
    Ennis, Madeleine
    Moore, John E.
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2019, 72 (12) : 837 - 838
  • [7] Treatment of Staphylococcus aureus in cystic fibrosis
    Elborn, JS
    [J]. THORAX, 1999, 54 (05) : 377 - 378
  • [8] Methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis
    Giron, Rosa M.
    Buendia, Buenaventura
    Pinedo, Celia
    Casanova, Alvaro
    Hoyos, Nieves
    Ancochea, Julio
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2009, 27 (02): : 85 - 88
  • [9] EPIDEMIOLOGY OF STAPHYLOCOCCUS-AUREUS IN PATIENTS WITH CYSTIC-FIBROSIS
    BRANGER, C
    FOURNIER, JM
    LOULERGUE, J
    BOUVET, A
    GOULLET, P
    BOUTONNIER, A
    DEGIALLULY, C
    COUETDIC, G
    CHOMARAT, M
    JAFFARBANJEE, MC
    MARIANI, P
    [J]. EPIDEMIOLOGY AND INFECTION, 1994, 112 (03): : 489 - 500
  • [10] Staphylococcus aureus with decreased susceptibility to glycopeptides in cystic fibrosis patients
    Filleron, Anne
    Chiron, Raphael
    Reverdy, Marie-Elisabeth
    Jean-Pierre, Helene
    Dumitrescu, Oana
    Aleyrangues, Linda
    Counil, Francois
    Jumas-Bilak, Estelle
    Marchandin, Helene
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2011, 10 (05) : 377 - 382